Fintepla oral solution 2.2 mg/mL, containing Fenfluramine hydrochloride, is manufactured by UCB Japan. Fintepla is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older. YJ code: 1139016S1020, Standard: 0．22%1mL.
Fintepla oral solution 2.2 mg/mL
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).